Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry

James K. Min, Allison Dunning, Fay Y. Lin, Stephan Achenbach, Mouaz H. Al-Mallah, Daniel S. Berman, Matthew J. Budoff, Filippo Cademartiri, Tracy Q. Callister, Hyuk-Jae Chang, Victor Cheng, Kavitha M. Chinnaiyan, Benjamin Chow, Augustin Delago, Martin Hadamitzky, Jorg Hausleiter, Ronald P. Karlsberg, Philipp Kaufmann, Erica Maffei, Khurram NasirMichael J. Pencina, Gilbert L. Raff, Leslee J. Shaw, Todd C. Villines

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Background: Coronary computed tomographic angiography (CCTA) of 64-detector rows or greater represents a novel noninvasive anatomic method for evaluation of patients with suspected coronary artery disease (CAD). Early studies suggest a potential for prognostic risk assessment by CCTA findings but were limited by small patient cohorts or single centers. The CONFIRM (COronary CT Angiography Evaluatio. N For Clinical Outcomes: An Inte. Rnational Multicenter) registry is a large, prospective, multinational dynamic observational study of patients undergoing CCTA. The primary aim of CONFIRM is to determine the prognostic value of CCTA findings for the prediction of future adverse CAD events. Methods: The CONFIRM registry currently represents 27,125 consecutive patients at 12 cluster sites in 6 countries in North America, Europe, and Asia. CONFIRM sites were chosen on the basis of adequate CCTA volume, site CCTA proficiency, and local demographic characteristics and medical facilities to ensure a broad-based sample of patients. Patients comprising the present CONFIRM cohort include those with suspected but without known CAD, with known CAD, or asymptomatic persons undergoing CAD evaluation. A data dictionary comprising a wide array of demographic, clinical, and CCTA findings was developed by the CONFIRM investigators and is uniformly used for all patients. Patients are followed up after CCTA performance to identify adverse CAD events, including death, myocardial infarction, unstable angina, target vessel revascularization, and CAD-related hospitalization. Conclusions: From a number of countries worldwide, the information collected from the CONFIRM registry will add incremental and important insights into CCTA findings that confer prognostic value beyond demographic and clinical characteristics. The results of the CONFIRM registry will provide valuable information about the optimal methods for using CCTA findings.

Original languageEnglish
Pages (from-to)84-92
Number of pages9
JournalJournal of Cardiovascular Computed Tomography
Volume5
Issue number2
DOIs
Publication statusPublished - 2011 Mar 1

Fingerprint

Coronary Angiography
Registries
Angiography
Coronary Artery Disease
Demography
Northern Asia
Computed Tomography Angiography
Unstable Angina
North America
Observational Studies
Hospitalization
Myocardial Infarction
Research Personnel

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Min, James K. ; Dunning, Allison ; Lin, Fay Y. ; Achenbach, Stephan ; Al-Mallah, Mouaz H. ; Berman, Daniel S. ; Budoff, Matthew J. ; Cademartiri, Filippo ; Callister, Tracy Q. ; Chang, Hyuk-Jae ; Cheng, Victor ; Chinnaiyan, Kavitha M. ; Chow, Benjamin ; Delago, Augustin ; Hadamitzky, Martin ; Hausleiter, Jorg ; Karlsberg, Ronald P. ; Kaufmann, Philipp ; Maffei, Erica ; Nasir, Khurram ; Pencina, Michael J. ; Raff, Gilbert L. ; Shaw, Leslee J. ; Villines, Todd C. / Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes : An InteRnational Multicenter) Registry. In: Journal of Cardiovascular Computed Tomography. 2011 ; Vol. 5, No. 2. pp. 84-92.
@article{a462211100dd491790a8779721392876,
title = "Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry",
abstract = "Background: Coronary computed tomographic angiography (CCTA) of 64-detector rows or greater represents a novel noninvasive anatomic method for evaluation of patients with suspected coronary artery disease (CAD). Early studies suggest a potential for prognostic risk assessment by CCTA findings but were limited by small patient cohorts or single centers. The CONFIRM (COronary CT Angiography Evaluatio. N For Clinical Outcomes: An Inte. Rnational Multicenter) registry is a large, prospective, multinational dynamic observational study of patients undergoing CCTA. The primary aim of CONFIRM is to determine the prognostic value of CCTA findings for the prediction of future adverse CAD events. Methods: The CONFIRM registry currently represents 27,125 consecutive patients at 12 cluster sites in 6 countries in North America, Europe, and Asia. CONFIRM sites were chosen on the basis of adequate CCTA volume, site CCTA proficiency, and local demographic characteristics and medical facilities to ensure a broad-based sample of patients. Patients comprising the present CONFIRM cohort include those with suspected but without known CAD, with known CAD, or asymptomatic persons undergoing CAD evaluation. A data dictionary comprising a wide array of demographic, clinical, and CCTA findings was developed by the CONFIRM investigators and is uniformly used for all patients. Patients are followed up after CCTA performance to identify adverse CAD events, including death, myocardial infarction, unstable angina, target vessel revascularization, and CAD-related hospitalization. Conclusions: From a number of countries worldwide, the information collected from the CONFIRM registry will add incremental and important insights into CCTA findings that confer prognostic value beyond demographic and clinical characteristics. The results of the CONFIRM registry will provide valuable information about the optimal methods for using CCTA findings.",
author = "Min, {James K.} and Allison Dunning and Lin, {Fay Y.} and Stephan Achenbach and Al-Mallah, {Mouaz H.} and Berman, {Daniel S.} and Budoff, {Matthew J.} and Filippo Cademartiri and Callister, {Tracy Q.} and Hyuk-Jae Chang and Victor Cheng and Chinnaiyan, {Kavitha M.} and Benjamin Chow and Augustin Delago and Martin Hadamitzky and Jorg Hausleiter and Karlsberg, {Ronald P.} and Philipp Kaufmann and Erica Maffei and Khurram Nasir and Pencina, {Michael J.} and Raff, {Gilbert L.} and Shaw, {Leslee J.} and Villines, {Todd C.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.jcct.2011.01.007",
language = "English",
volume = "5",
pages = "84--92",
journal = "Journal of Cardiovascular Computed Tomography",
issn = "1934-5925",
publisher = "Elsevier Inc.",
number = "2",

}

Min, JK, Dunning, A, Lin, FY, Achenbach, S, Al-Mallah, MH, Berman, DS, Budoff, MJ, Cademartiri, F, Callister, TQ, Chang, H-J, Cheng, V, Chinnaiyan, KM, Chow, B, Delago, A, Hadamitzky, M, Hausleiter, J, Karlsberg, RP, Kaufmann, P, Maffei, E, Nasir, K, Pencina, MJ, Raff, GL, Shaw, LJ & Villines, TC 2011, 'Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry', Journal of Cardiovascular Computed Tomography, vol. 5, no. 2, pp. 84-92. https://doi.org/10.1016/j.jcct.2011.01.007

Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes : An InteRnational Multicenter) Registry. / Min, James K.; Dunning, Allison; Lin, Fay Y.; Achenbach, Stephan; Al-Mallah, Mouaz H.; Berman, Daniel S.; Budoff, Matthew J.; Cademartiri, Filippo; Callister, Tracy Q.; Chang, Hyuk-Jae; Cheng, Victor; Chinnaiyan, Kavitha M.; Chow, Benjamin; Delago, Augustin; Hadamitzky, Martin; Hausleiter, Jorg; Karlsberg, Ronald P.; Kaufmann, Philipp; Maffei, Erica; Nasir, Khurram; Pencina, Michael J.; Raff, Gilbert L.; Shaw, Leslee J.; Villines, Todd C.

In: Journal of Cardiovascular Computed Tomography, Vol. 5, No. 2, 01.03.2011, p. 84-92.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes

T2 - An InteRnational Multicenter) Registry

AU - Min, James K.

AU - Dunning, Allison

AU - Lin, Fay Y.

AU - Achenbach, Stephan

AU - Al-Mallah, Mouaz H.

AU - Berman, Daniel S.

AU - Budoff, Matthew J.

AU - Cademartiri, Filippo

AU - Callister, Tracy Q.

AU - Chang, Hyuk-Jae

AU - Cheng, Victor

AU - Chinnaiyan, Kavitha M.

AU - Chow, Benjamin

AU - Delago, Augustin

AU - Hadamitzky, Martin

AU - Hausleiter, Jorg

AU - Karlsberg, Ronald P.

AU - Kaufmann, Philipp

AU - Maffei, Erica

AU - Nasir, Khurram

AU - Pencina, Michael J.

AU - Raff, Gilbert L.

AU - Shaw, Leslee J.

AU - Villines, Todd C.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Background: Coronary computed tomographic angiography (CCTA) of 64-detector rows or greater represents a novel noninvasive anatomic method for evaluation of patients with suspected coronary artery disease (CAD). Early studies suggest a potential for prognostic risk assessment by CCTA findings but were limited by small patient cohorts or single centers. The CONFIRM (COronary CT Angiography Evaluatio. N For Clinical Outcomes: An Inte. Rnational Multicenter) registry is a large, prospective, multinational dynamic observational study of patients undergoing CCTA. The primary aim of CONFIRM is to determine the prognostic value of CCTA findings for the prediction of future adverse CAD events. Methods: The CONFIRM registry currently represents 27,125 consecutive patients at 12 cluster sites in 6 countries in North America, Europe, and Asia. CONFIRM sites were chosen on the basis of adequate CCTA volume, site CCTA proficiency, and local demographic characteristics and medical facilities to ensure a broad-based sample of patients. Patients comprising the present CONFIRM cohort include those with suspected but without known CAD, with known CAD, or asymptomatic persons undergoing CAD evaluation. A data dictionary comprising a wide array of demographic, clinical, and CCTA findings was developed by the CONFIRM investigators and is uniformly used for all patients. Patients are followed up after CCTA performance to identify adverse CAD events, including death, myocardial infarction, unstable angina, target vessel revascularization, and CAD-related hospitalization. Conclusions: From a number of countries worldwide, the information collected from the CONFIRM registry will add incremental and important insights into CCTA findings that confer prognostic value beyond demographic and clinical characteristics. The results of the CONFIRM registry will provide valuable information about the optimal methods for using CCTA findings.

AB - Background: Coronary computed tomographic angiography (CCTA) of 64-detector rows or greater represents a novel noninvasive anatomic method for evaluation of patients with suspected coronary artery disease (CAD). Early studies suggest a potential for prognostic risk assessment by CCTA findings but were limited by small patient cohorts or single centers. The CONFIRM (COronary CT Angiography Evaluatio. N For Clinical Outcomes: An Inte. Rnational Multicenter) registry is a large, prospective, multinational dynamic observational study of patients undergoing CCTA. The primary aim of CONFIRM is to determine the prognostic value of CCTA findings for the prediction of future adverse CAD events. Methods: The CONFIRM registry currently represents 27,125 consecutive patients at 12 cluster sites in 6 countries in North America, Europe, and Asia. CONFIRM sites were chosen on the basis of adequate CCTA volume, site CCTA proficiency, and local demographic characteristics and medical facilities to ensure a broad-based sample of patients. Patients comprising the present CONFIRM cohort include those with suspected but without known CAD, with known CAD, or asymptomatic persons undergoing CAD evaluation. A data dictionary comprising a wide array of demographic, clinical, and CCTA findings was developed by the CONFIRM investigators and is uniformly used for all patients. Patients are followed up after CCTA performance to identify adverse CAD events, including death, myocardial infarction, unstable angina, target vessel revascularization, and CAD-related hospitalization. Conclusions: From a number of countries worldwide, the information collected from the CONFIRM registry will add incremental and important insights into CCTA findings that confer prognostic value beyond demographic and clinical characteristics. The results of the CONFIRM registry will provide valuable information about the optimal methods for using CCTA findings.

UR - http://www.scopus.com/inward/record.url?scp=79953690811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953690811&partnerID=8YFLogxK

U2 - 10.1016/j.jcct.2011.01.007

DO - 10.1016/j.jcct.2011.01.007

M3 - Article

C2 - 21477786

AN - SCOPUS:79953690811

VL - 5

SP - 84

EP - 92

JO - Journal of Cardiovascular Computed Tomography

JF - Journal of Cardiovascular Computed Tomography

SN - 1934-5925

IS - 2

ER -